Literature DB >> 1465987

Tolerance to skin and vascularized cardiac allografts using mixed chimerism.

P M Markus1, G Selvaggi, X Cai, T E Starzl, H D Röher.   

Abstract

Mesh:

Substances:

Year:  1992        PMID: 1465987      PMCID: PMC3091366     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

Review 1.  Cellular factors. Immunologic tolerance: irradiation and bone marrow transplantation in induction of canine allogeneic unresponsiveness.

Authors:  F T Rapaport; R J Bachvaroff; K Watanabe; H Hirasawa; F D Cannon; N Mollen; D A Blumenstock; J H Ayvazian; J W Ferrebee
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

2.  Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).

Authors:  S T Ildstad; S M Wren; J A Bluestone; S A Barbieri; D Stephany; D H Sachs
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

3.  Successful cardiac allografts in syngeneic radiation chimeras.

Authors:  J Dittmer; M Bennett
Journal:  Mol Cell Biochem       Date:  1978-11-01       Impact factor: 3.396

4.  Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts.

Authors:  S T Ildstad; D H Sachs
Journal:  Nature       Date:  1984 Jan 12-18       Impact factor: 49.962

5.  Transplantation tolerance in primates following total lymphoid irradiation and allogeneic bone marrow injection. I. Orthotopic liver allografts.

Authors:  J A Myburgh; J A Smit; S Browde; R R Hill
Journal:  Transplantation       Date:  1980-05       Impact factor: 4.939

6.  Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts.

Authors:  S Slavin; S Strober; Z Fuks; H S Kaplan
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.